RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial

Condition:   Severe Aplastic Anemia Intervention:   Drug: ATGAM plus CsA with or without Eltrombopag Sponsor:   European Group for Blood and Marrow Transplantation Enrolling by invitation

Source: ClinicalTrials.gov - September 20, 2021 Category: Research Source Type: clinical trials